John M. Engel
Advertisement
John M. Engel is the managing partner at Engel & Novitt, LLP
Articles by John M. Engel
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Biocon’s Pebrilzo Becomes First Breast Cancer Treatment Biosimilar Approved Under EMA’s Tailored Clinical Approach
2
SELLAS Cancer Vaccine Improves Overall Survival in Phase 3 AML Trial
3
The BioPharm Brief: A First for Streamlined Biosimilar Approval, a Head-to-Head Bispecific Trial in Wet AMD, and In Vivo KIR-CAR T
4
Visara Doses First Patient in Phase 2b Trial Pitting Bispecific VIS-101 Against Aflibercept in Wet AMD
5

